The University of Plymouth is working with a global pharmaceutical company to test a new app to help people with multiple sclerosis (MS) better manage their symptoms.
Roche, a world-leader in personalised healthcare, has developed an app called Floodlight MS, with five activities collecting data on hand function, walking ability, and cognition – areas commonly affected in people living with MS.
Floodlight™ MS is a science-based smartphone app that enables people living with MS to objectively assess their physical and cognitive function in between medical appointments. The app creates for clinicians a record of data to inform future conversations and enrich clinical decisions.
Roche has a longstanding relationship with Professor Jeremy Hobart and the MS research group at the University of Plymouth to co-design projects that help improve the quality of life for people with MS. Identifying a collaboration that could help move the new app forward, Professor Hobart made an introduction to the Motor Control Lab in the University’s new Brain Research and Imaging Centre.
The lab, led by Professor in Rehabilitation, Jon Marsden, contains world-leading technology that will enable Roche to test and validate the app’s accuracy, while continually feeding the results into product development.
The work will see participants use Floodlight MS on provided mobile phones, with researchers independently exploring if the measures recorded by the device are comparable to the measures of movement quality recorded in the lab itself, therefore ensuring that the app is working as intended.
